RecensMedical

리센스메디컬 · 394420

Health Care Medical Devices · KOSDAQ

Small-cap

Market cap US$166.8M (₩230.2B)

Overview

RecensMedical develops medical devices that cool living tissue with high precision, targeting conditions such as acne, eczema, psoriasis, and hair loss, areas where heat-based treatments like lasers cannot be used.

Its technology uses the physical expansion of a liquid cryogenic refrigerant to control cooling temperature rapidly and precisely, overcoming the limited accuracy of conventional cold-therapy methods. Listed on KOSDAQ, Korea's tech-focused small-cap exchange, the company's core business is built around this proprietary precision-cooling platform as its single underlying technology.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$6.4M
Operating profit · FY2025
−US$7.7M
Net income · FY2025
−US$13.9M

Revenue

  • FY2025US$6.4M

Operating profit

  • FY2025−US$7.7M

Net income

  • FY2025−US$13.9M

Key ratios (FY2025)

ROE
-274.0%
Debt/Eq
72.1%
Op. margin
-120.5%
Net margin
-216.6%
Rev. YoY
N/A (see filing)

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.